Correlation Between Ensysce Biosciences and Climb Bio
Can any of the company-specific risk be diversified away by investing in both Ensysce Biosciences and Climb Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ensysce Biosciences and Climb Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ensysce Biosciences and Climb Bio, you can compare the effects of market volatilities on Ensysce Biosciences and Climb Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ensysce Biosciences with a short position of Climb Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ensysce Biosciences and Climb Bio.
Diversification Opportunities for Ensysce Biosciences and Climb Bio
0.71 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Ensysce and Climb is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Ensysce Biosciences and Climb Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Climb Bio and Ensysce Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ensysce Biosciences are associated (or correlated) with Climb Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Climb Bio has no effect on the direction of Ensysce Biosciences i.e., Ensysce Biosciences and Climb Bio go up and down completely randomly.
Pair Corralation between Ensysce Biosciences and Climb Bio
If you would invest 0.90 in Ensysce Biosciences on September 22, 2024 and sell it today you would earn a total of 0.00 from holding Ensysce Biosciences or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 4.76% |
Values | Daily Returns |
Ensysce Biosciences vs. Climb Bio
Performance |
Timeline |
Ensysce Biosciences |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Climb Bio |
Ensysce Biosciences and Climb Bio Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Ensysce Biosciences and Climb Bio
The main advantage of trading using opposite Ensysce Biosciences and Climb Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ensysce Biosciences position performs unexpectedly, Climb Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Climb Bio will offset losses from the drop in Climb Bio's long position.Ensysce Biosciences vs. Ensysce Biosciences | Ensysce Biosciences vs. NRx Pharmaceuticals | Ensysce Biosciences vs. Faraday Future Intelligent |
Climb Bio vs. Dogwood Therapeutics, | Climb Bio vs. Eupraxia Pharmaceuticals Common | Climb Bio vs. CERo Therapeutics Holdings | Climb Bio vs. Opus Genetics, |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |